Innovation

New organisms, new materials, new methods, new uses, new claims… Where do you start? Start with ATS Labs! We do new!!

For new organisms, we work closely with academics, government agencies, and numerous culture collections to both acquire the organisms and develop the strain-specific methods to enable efficacy testing to support new claims.

We recently developed methods for handling C. difficile to enable sporicidal testing. We also acquired a low pathogenicity strain of Avian Influenza subtype H5N1 and are set up for testing.

For new materials, we often create new test methods to support new uses and new claims. Working together toward your business goals, we will develop testing programs and help execute regulatory strategies that enable your commercial success!

We do new!! We have done it before. We can do it for you!